Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps
Clinical trial NCT06850805 · RECRUITING
Trial details
- NCT number
- NCT06850805
- Sponsor
- Optinose US Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-28
- Primary completion
- 2028-03-31
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.